ConductScience.org, home

Paper8909668

Alveolar overdistension is an important mechanism of persistent lung damage following severe protracted ARDS.

Finfer S and 1 other. Anaesth Intensive Care, 1996. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Alveolar overdistension is an important mechanism of persistent lung damage following severe protracted ARDS. Papers, record 8909668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8909668

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alveolar overdistension is an important mechanism of persistent lung damage following severe protracted ARDS.
PubMed
Journal
Anaesth Intensive Care
PubMed
Year
1996
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1
iCite
Revised in PubMed
2020-12-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Finfer SS
2Rocker GG

Source PubMed

Download CSV of authors

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LungMajor topic
Pulmonary AlveoliMajor topic
Respiratory Distress SyndromeMajor topic
Adolescent
Adult
Bacterial Infections
Barotrauma
Bronchiectasis
Cysts
Female
Follow-Up Studies
Humans
Hydropneumothorax
Ischemia
Lung Diseases
Male
Pleural Diseases
Pleural Effusion
Pneumothorax
Pulmonary Atelectasis
Radiographic Image Enhancement
Respiration, Artificial
Retrospective Studies
Stress, Mechanical
Tidal Volume
Tomography, X-Ray Computed

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
38322185Pneumomediastinum and pneumothorax in acute respiratory distress syndrome (ARDS) patients: a narrative review.Mediastinum2024https://conductscience.org/library/papers/38322185PubMed
36950541Clinical review of high-flow nasal oxygen therapy in human and veterinary patients.Front Vet Sci2023https://conductscience.org/library/papers/36950541PubMed
35329965
Bedside Selection of Positive End Expiratory Pressure by Electrical Impedance Tomography in Patients Undergoing Veno-Venous Extracorporeal Membrane Oxygenation Support: A Comparison between COVID-19 ARDS and ARDS from Other Etiologies.
J Clin Med2022https://conductscience.org/library/papers/35329965PubMed
33138976High incidence and mortality of pneumothorax in critically Ill patients with COVID-19.Heart Lung2021https://conductscience.org/library/papers/33138976PubMed
25337400Acute respiratory distress syndrome and pneumothorax.J Thorac Dis2014https://conductscience.org/library/papers/25337400PubMed
17302983Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability.Crit Care2007https://conductscience.org/library/papers/17302983PubMed
17274806Mechanical ventilation and lung infection in the genesis of air-space enlargement.Crit Care2007https://conductscience.org/library/papers/17274806PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8909668

GET https://conductscience.org/api/papers/v1/8909668/authors